Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 989-996

  You, Y Nancy ^a   Habiba, Halim ^a   Chang, George J ^a   Rodriguez Bigas, Miguel A ^a   Skibber, John M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAIN ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM CANCER; RECURRENT CANCER; WELLBEING;

FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAIN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECTAL NEOPLASMS; SURVIVAL RATE; SURVIVORS;

EID: 79955818662     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1218-6     Document Type: Article

References (34)

1. Heald RJ. The 'Holy Plane' of rectal surgery. J R Soc Med. 1988;81:503-8.
2. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-40.
3. Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2009. doi:10.1111/j.1463-1318.2009.02167.x.
4. Silberfein EJ, Kattepogu KM, Hu CY, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17L:2863-9.
5. Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol. 2001;27:349-53. (Pubitemid 32624535)
6. de Chaisemartin C, Penna C, Goere D, et al. Presentation and prognosis of local recurrence after total mesorectal excision. Color Dis. 2009;11:60-6.
7. Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol. 2008;14:6018-23.
8. Palmer G, Martling A, Cedermark B, Holm T. A populationbased study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2007;14:447-54. (Pubitemid 46175288)
9. Bedrosian I, Giacco G, Pederson L, et al. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006;49:175-82. (Pubitemid 43219952)
10. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Barriers to rehabilitation of colorectal cancer patients. J Surg Oncol. 2007; 95:400-8. (Pubitemid 46697203)
11. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-9. (Pubitemid 23071057)
12. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999;8:181-95. (Pubitemid 29367288)
13. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994; 330:592-6. (Pubitemid 24065792)
14. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-38.
15. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19. (Pubitemid 40038441)
16. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105-21. (Pubitemid 351147828)
17. Cleeland CS. The brief pain inventory user guide. Houston, TX: The University of Texas M. D. Anderson Cancer Center; 2009.
18. FACT-C scoring sheet. cited; Available from: www.facit.org.Last accessed April 1, 2010.
19. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502-8. (Pubitemid 38176430)
20. Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD. Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2003;10:72-9.
21. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum. 2005;48:929-37. (Pubitemid 40884181)
22. Caricato M, Borzomati D, Ausania F, Valeri S, Rosignoli A, Coppola R. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol. 2006;32:126-32. (Pubitemid 43257110)
23. Hansen MH, Balteskard L, Dorum LM, Eriksen MT, Vonen B. Locally recurrent rectal cancer in Norway. Br J Surg. 2009; 96:1176-82.
24. Kusters M, Dresen RC, Martijn H, et al. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2009;75:1444-9.
25. Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum. 2000;43: 1695-701; discussion 701-3.
26. Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10:865-71.
27. Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547-56.
28. Halabi S, Vogelzang NJ, Kornblith AB, et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol. 2008;26:2544-9.
29. Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol. 2008;108:100-5. (Pubitemid 350299429)
30. Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D. Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer. 2002;38:1351-7. (Pubitemid 34686846)
31. Sullivan PW, Nelson JB, Mulani PM, Sleep D. Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res. 2006;15:1297-306. (Pubitemid 44673606)
32. Movsas B, Moughan J, Sarna L, et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009;27:5816-22.
33. Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361-7. (Pubitemid 35266298)
34. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8:189-98.